Add
AMLN to Portfolio
Set Alert
Email to a
Friend
| |||
|
|
Quotes & Info
|
| AMLN > SEC Filings for AMLN > Form 8-K on 29-Jan-2009 | All Recent SEC Filings |
29-Jan-2009
Other Events, Financial Statements and Exhibits
On January 29, 2009, Amylin Pharmaceuticals, Inc. ("Amylin") issued a press release confirming that it has reviewed an amended 13-D filing with the Securities and Exchange Commission from Amylin shareholder Icahn Capital LP and affiliated funds announcing their intent to nominate a slate of five directors to stand for election at Amylin's 2009 annual meeting. Amylin has not yet received the required notice with respect to this action.
Amylin's Corporate Governance Committee is engaged in a process to recommend a slate for election at the company's annual meeting. It is reviewing potential nominees suggested by shareholders as part of that process, including two individuals previously discussed with representatives of the Icahn funds. Once the process has been completed, Amylin's Board of Directors will formally recommend a slate of nominees that it believes will act in the best interest of all shareholders.
A copy of the press release is attached as Exhibit 99.1 and is incorporated herein by reference.
(d) Exhibits.
99.1 Press release issued by Amylin on January 29, 2009.
|
|